Bilosomes in the context of oral immunization: development, challenges and opportunities

被引:74
作者
Shukla, Anshuman [1 ]
Mishra, Vijay [2 ]
Kesharwani, Prashant [3 ]
机构
[1] Panjab Univ, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
[2] Adina Inst Pharmaceut Sci, Pharmaceut Nanotechnol Res Lab, Sagar 470002, India
[3] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Detroit, MI 48201 USA
关键词
BILE-SALTS; M-CELLS; SYSTEMIC IMMUNITY; DELIVERY-SYSTEM; MUCOSAL; DRUG; VESICLES; TETANUS; BIOAVAILABILITY; NANOPARTICLES;
D O I
10.1016/j.drudis.2016.03.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Oral administration remains the most favored means of drug administration as far as patient compliance is concerned. For the majority of vaccines and biologics, the oral route is not a good choice because of diminished uptake of the administered dose. Vesicular carriers like liposomes and niosomes are among the potential candidates for vaccine delivery by the oral route but their instability in the gastrointestinal environment is a problem. Bilosomes represent a key advance in oral vaccine delivery because they are more resistant to disruption by gastric acid as well as enzymes. Here, we focus on different aspects of bilosomes including composition, developmental techniques, stability, transitional modifications and scale-up - emphasizing their biomedical potential in oral immunization against various diseases.
引用
收藏
页码:888 / 899
页数:12
相关论文
共 51 条
  • [1] [Anonymous], 2009, STAT WORLDS VACC IMM
  • [2] Arora D., 2011, Int. J. Recent Adv. Pharm. Res, V1, P45
  • [3] Atkinson W., 2011, EPIDEMIOLOGY PREVENT
  • [4] Translational modifications to improve vaccine efficacy in an oral influenza vaccine
    Bennett, Ewan
    Mullen, Alexander B.
    Ferro, Valerie A.
    [J]. METHODS, 2009, 49 (04) : 322 - 327
  • [5] Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers
    Borges, Olga
    Lebre, Filipa
    Bento, Dulce
    Borchard, Gerrit
    Junginger, Hans E.
    [J]. PHARMACEUTICAL RESEARCH, 2010, 27 (02) : 211 - 223
  • [6] Intestinal Peyer's patch M cells and oral vaccine targeting
    Brayden, DJ
    Jepson, MA
    Baird, AW
    [J]. DRUG DISCOVERY TODAY, 2005, 10 (17) : 1145 - 1157
  • [7] Clark MA, 2001, VACCINE, V20, P208
  • [8] Exploiting M cells for drug and vaccine delivery
    Clark, MA
    Jepson, MA
    Hirst, BH
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 (1-2) : 81 - 106
  • [9] Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)
    Conacher, M
    Alexander, J
    Brewer, JM
    [J]. VACCINE, 2001, 19 (20-22) : 2965 - 2974
  • [10] Csaba Noemi, 2006, Expert Opin Drug Deliv, V3, P463, DOI 10.1517/17425247.3.4.463